PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.30%
Negative revenue growth while MU stands at 43.65%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-4.22%
Negative gross profit growth while MU is at 106.08%. Joel Greenblatt would examine cost competitiveness or demand decline.
15.97%
EBIT growth below 50% of MU's 168.35%. Michael Burry would suspect deeper competitive or cost structure issues.
15.09%
Operating income growth under 50% of MU's 168.35%. Michael Burry would be concerned about deeper cost or sales issues.
-6.77%
Negative net income growth while MU stands at 164.35%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-2.56%
Negative EPS growth while MU is at 156.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-2.63%
Negative diluted EPS growth while MU is at 147.92%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.73%
Share reduction more than 1.5x MU's 7.17%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
17.08%
Diluted share count expanding well above MU's 7.58%. Michael Burry would fear significant dilution to existing owners' stakes.
4.95%
Dividend growth of 4.95% while MU is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
34.22%
OCF growth under 50% of MU's 89.13%. Michael Burry might suspect questionable revenue recognition or rising costs.
-197.20%
Negative FCF growth while MU is at 114.69%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
29.76%
10Y revenue/share CAGR under 50% of MU's 1423.49%. Michael Burry would suspect a lasting competitive disadvantage.
-26.65%
Negative 5Y CAGR while MU stands at 82.74%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
12.01%
3Y revenue/share CAGR under 50% of MU's 103.23%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-2.10%
Negative 10Y OCF/share CAGR while MU stands at 1470.65%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
7.60%
Below 50% of MU's 88.67%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
24.27%
3Y OCF/share CAGR under 50% of MU's 298.61%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
953.20%
Below 50% of MU's 15019.46%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
90.10%
5Y net income/share CAGR similar to MU's 88.95%. Walter Schloss might see both on parallel mid-term trajectories.
299.75%
Below 50% of MU's 655.14%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
302.95%
Below 50% of MU's 729.13%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
168.64%
5Y equity/share CAGR 1.25-1.5x MU's 147.93%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
91.42%
3Y equity/share CAGR 1.25-1.5x MU's 66.91%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
21.42%
Dividend/share CAGR of 21.42% while MU is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-2.02%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-2.13%
Negative near-term dividend growth while MU invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-6.69%
Firm’s AR is declining while MU shows 23.53%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
9.89%
Inventory growth well above MU's 9.83%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-3.38%
Negative asset growth while MU invests at 17.30%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.45%
Under 50% of MU's 6.78%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-3.74%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-17.26%
Our R&D shrinks while MU invests at 30.91%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-11.48%
We cut SG&A while MU invests at 3.66%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.